The issue is much more complex. https://www.forbes.com/sites/johnlamattina/2013/04/08/indias-solution-to-drug-costs-ignore-patents-and-control-prices-ex https:

The issue is much more complex. https://www.forbes.com/sites/johnlamattina/2013/04/08/indias-solution-to-drug-costs-ignore-patents-and-control-prices-ex https://www.forbes.com/sites/johnlamattina/2013/04/08/indias...